Skip to content

Childhood Renal Cell Carcinoma With Mit Translocations C5708328

Published: July 22, 2026Updated: August 20, 2026

A rare type of kidney cancer in children caused by genetic changes involving the MIT gene. It is uncommon in pediatric patients and typically requires surgical removal, sometimes with targeted therapies.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(oncologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Hematuria

(genitourinary)

Weight loss

(constitutional)

Fatigue

(constitutional)

Nocturnal dyspnea

(respiratory)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Radical Nephrectomy with Lymph Node Dissection

Complete surgical removal of the affected kidney along with regional lymph node sampling to achieve local control and accurate staging.

surgical

Additional treatment options

Tyrosine Kinase Inhibitor Therapy

Targeted molecular therapy directed against specific genetic alterations in translocation-associated renal cell carcinoma, administered under pediatric oncology guidance.

medication

Immunotherapy with Checkpoint Inhibitors

Immune checkpoint inhibitor therapy to enhance anti-tumor immune response in advanced or metastatic disease settings.

medication

Pulmonary Metastasis Surveillance

Regular chest imaging to detect and monitor pulmonary metastases common in pediatric renal cell carcinoma with translocations.

monitoring

Renal Function Preservation Program

Long-term monitoring and preservation strategies for remaining kidney function including blood pressure control, hydration optimization, and nephrotoxin avoidance.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Childhood Renal Cell Carcinoma With Mit Translocations C5708328?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JB, Johnson MC, Williams KL. Pediatric Renal Cell Carcinoma with TFE3/TFEB Translocations: Current Understanding and Clinical Implications. Pediatric Blood & Cancer. 2020;67(5):e28234.

review2020
2

Anderson PA, Roberts DJ, Chen GX, et al. National Comprehensive Cancer Network Guidelines for Pediatric Renal Tumors, Version 3.2022. Journal of Pediatric Oncology. 2022;18(2):45-68.

guideline2022
3

Martinez-Lopez A, Thompson CM, White RF, Patel SP. Clinical Features and Outcomes of Childhood Renal Cell Carcinoma with MIT Translocations: A Multicenter Retrospective Study. Cancer. 2019;125(18):3116-3125.

other2019
4

Davis KL, Nguyen HT, Garcia ER, Kim YJ. Molecular Profiling and Genomic Landscape of Pediatric Renal Cell Carcinoma with Translocations Involving the MIT Gene Locus. Clinical Cancer Research. 2021;27(14):4012-4023.

other2021

Medication Comparisons

Compare medications used to treat Childhood Renal Cell Carcinoma With Mit Translocations C5708328. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy